DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BMS-919373
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome; Atrial Fibrillation
Unknown
BMS-919373
×
Maximum Phase:
2
First Approval:
None
UNII:
NGB50MQK8N
Molecule Type:
Small molecule
Molecular Formula:
C25H20N6O2S
Molecular Weight:
468.54
AlogP:
4.01
PSA:
123.75
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY-518674
2
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia; Hypertension; Metabolic Syndrome
Peroxisome proliferator-activated receptor alpha agonist
LY-518674
×
Maximum Phase:
2
First Approval:
None
UNII:
U8I57RC739
Molecule Type:
Small molecule
Molecular Formula:
C23H27N3O4
Molecular Weight:
409.49
AlogP:
3.76
PSA:
97.47
HBD:
2.0
HBA:
#RotB:
9.0
Source:
RIBOSE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RIBOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MBX-2044
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Peroxisome proliferator-activated receptor gamma modulator
MBX-2044
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CABIRALIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Neoplasms; Synovitis, Pigmented Villonodular; Carcinoma, Hepatocellular; Lymphoma, T-Cell, Peripheral; Pancreatic Neoplasms
Macrophage colony stimulating factor receptor antagonist
CABIRALIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
5FJL6W0640
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCS110
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MCS110
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPACYTARABINE
2
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute
DNA disrupting agent
ASPACYTARABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
JL7V54Z2BR
Molecule Type:
Small molecule
Molecular Formula:
C13H18N4O8
Molecular Weight:
358.31
AlogP:
-3.4
PSA:
197.23
HBD:
6.0
HBA:
#RotB:
6.0
Source:
PALOSURAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Urotensin II receptor antagonist
PALOSURAN
×
Maximum Phase:
2
First Approval:
None
UNII:
ULD9ZKE457
Molecule Type:
Small molecule
Molecular Formula:
C25H30N4O2
Molecular Weight:
418.54
AlogP:
3.73
PSA:
77.49
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TOMIVOSERTIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Prostatic Neoplasms, Castration-Resistant
MAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor
TOMIVOSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
U2H19X4WBV
Molecule Type:
Small molecule
Molecular Formula:
C17H20N6O2
Molecular Weight:
340.39
AlogP:
1.63
PSA:
114.93
HBD:
3.0
HBA:
#RotB:
2.0
Source:
SOLABEGRON
2
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder, Overactive
Beta-3 adrenergic receptor agonist
SOLABEGRON
×
Maximum Phase:
2
First Approval:
None
UNII:
55P6YH9O6N
Molecule Type:
Small molecule
Molecular Formula:
C23H23ClN2O3
Molecular Weight:
410.9
AlogP:
4.44
PSA:
81.59
HBD:
4.0
HBA:
#RotB:
9.0
Source:
LXH254
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LXH254
×
Maximum Phase:
2
First Approval:
None
UNII:
15JL80DG6H
Molecule Type:
Small molecule
Molecular Formula:
C25H25F3N4O4
Molecular Weight:
502.49
AlogP:
3.93
PSA:
96.81
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BFPET
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Diagnostic
BFPET
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H19FP+
Molecular Weight:
357.39
AlogP:
4.45
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LMB-2
2
Antibody
Investigational
Unknown
Unknown
Leukemia-Lymphoma, Adult T-Cell; Leukemia; Leukemia, Hairy Cell; Lymphoma
Elongation factor 2 inhibitor
LMB-2
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(-)-PROPANOLOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
(-)-PROPANOLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
74MLR03FLC
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2
Molecular Weight:
259.35
AlogP:
2.58
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BEMCENTINIB
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Melanoma; Myelodysplastic Syndromes; Neoplasms; Pancreatic Neoplasms; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Inflammatory Breast Neoplasms; Mesothelioma; Severe Acute Respiratory Syndrome
Tyrosine-protein kinase receptor UFO inhibitor
BEMCENTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0ICW2LX8AS
Molecule Type:
Small molecule
Molecular Formula:
C30H34N8
Molecular Weight:
506.66
AlogP:
4.88
PSA:
97.78
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NM-404 I-124
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NM-404 I-124
×
Maximum Phase:
2
First Approval:
None
UNII:
08W354EC17
Molecule Type:
Small molecule
Molecular Formula:
C29H53INO4P
Molecular Weight:
634.63
AlogP:
8.28
PSA:
58.59
HBD:
0.0
HBA:
#RotB:
24.0
Source:
PAC-14028
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Seborrheic; Pruritus; Rosacea; Dermatitis, Atopic
Vanilloid receptor antagonist
PAC-14028
×
Maximum Phase:
2
First Approval:
None
UNII:
3VF7K7Z10B
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VX15
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
VX15
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOFORMINOL
2
Unknown
Investigational
Unknown
Unknown
Unknown
Diagnostic
IOFORMINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
95FNF21CDN
Molecule Type:
Unknown
Molecular Formula:
C33H40I6N6O15
Molecular Weight:
1522.13
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PF-05212384
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-05212384
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUBROBENGUANE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUBROBENGUANE
×
Maximum Phase:
2
First Approval:
None
UNII:
XCG95AYX3B
Molecule Type:
Small molecule
Molecular Formula:
C11H15BrFN3O
Molecular Weight:
304.16
AlogP:
2.17
PSA:
71.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
DEXELVUCITABINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
DEXELVUCITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
KU8SPJ271W
Molecule Type:
Small molecule
Molecular Formula:
C9H10FN3O3
Molecular Weight:
227.19
AlogP:
-0.59
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
SVN53-67/M57-KLH PEPTIDE VACCINE
2
Protein
Investigational
Unknown
Unknown
Leukemia, Plasma Cell; Multiple Myeloma; Glioblastoma; Gliosarcoma
Baculoviral IAP repeat-containing protein 5 vaccine antigen
SVN53-67/M57-KLH PEPTIDE VACCINE
×
Maximum Phase:
2
First Approval:
None
UNII:
HK7BJ56KSP
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HU14.18-IL2
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
HU14.18-IL2
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STX107
2
Small molecule
Investigational
Unknown
Unknown
Fragile X Syndrome
Metabotropic glutamate receptor 5 negative allosteric modulator
STX107
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C18H10FN3S
Molecular Weight:
319.36
AlogP:
3.92
PSA:
49.57
HBD:
0.0
HBA:
#RotB:
1.0
Source:
SPEBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia
Unknown
SPEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
DRU6NG543J
Molecule Type:
Small molecule
Molecular Formula:
C22H22FN5O3
Molecular Weight:
423.45
AlogP:
4.25
PSA:
97.4
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MK-0533
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Peroxisome proliferator-activated receptor gamma modulator
MK-0533
×
Maximum Phase:
2
First Approval:
None
UNII:
J17152066B
Molecule Type:
Small molecule
Molecular Formula:
C28H24F3NO6
Molecular Weight:
527.5
AlogP:
6.32
PSA:
86.99
HBD:
1.0
HBA:
#RotB:
9.0
Source:
F-18
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
F-18
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
HF
Molecular Weight:
19.01
AlogP:
0.15
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
QUILIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal; Asthma; Urticaria
Ig epsilon chain C region inhibitor
QUILIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
26F96HRJ3W
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMPELOPSIN
2
Small molecule
Investigational
Unknown
Unknown
Alcohol-Related Disorders; Diabetes Mellitus, Type 2
Unknown
AMPELOPSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KD8QND6427
Molecule Type:
Small molecule
Molecular Formula:
C15H12O8
Molecular Weight:
320.25
AlogP:
0.89
PSA:
147.68
HBD:
6.0
HBA:
#RotB:
1.0
Source:
IRATUMUMAB
2
Antibody
Investigational
Unknown
Unknown
Lymphoma; Hematologic Neoplasms; Hodgkin Disease
Tumor necrosis factor receptor superfamily member 8 other
IRATUMUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
AYH22O1B1U
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EZUTROMID
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Utrophin modulator
EZUTROMID
×
Maximum Phase:
2
First Approval:
None
UNII:
645R07LF0D
Molecule Type:
Small molecule
Molecular Formula:
C19H15NO3S
Molecular Weight:
337.4
AlogP:
4.44
PSA:
60.17
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SCH-486757
2
Small molecule
Investigational
Unknown
Unknown
Cough
Nociceptin receptor agonist
SCH-486757
×
Maximum Phase:
2
First Approval:
None
UNII:
2HV668N62T
Molecule Type:
Small molecule
Molecular Formula:
C24H23Cl2N3O
Molecular Weight:
440.37
AlogP:
5.39
PSA:
49.25
HBD:
1.0
HBA:
#RotB:
4.0
Source:
KB003
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
KB003
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVAROFLOXACIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AVAROFLOXACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
070SV15RJA
Molecule Type:
Small molecule
Molecular Formula:
C21H23F2N3O4
Molecular Weight:
419.43
AlogP:
2.96
PSA:
97.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
185
186
187
188
189
190
191
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA